View Future GrowthInnospec 過去の業績過去 基準チェック /46Innospecの収益は年間平均-3.8%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4.4% 5.2%割合で 増加しています。 Innospecの自己資本利益率は8.4%であり、純利益率は6.4%です。主要情報-3.83%収益成長率-4.02%EPS成長率Chemicals 業界の成長12.41%収益成長率5.18%株主資本利益率8.42%ネット・マージン6.38%前回の決算情報31 Mar 2026最近の業績更新お知らせ • Apr 08Innospec Inc. to Report Q1, 2026 Results on May 07, 2026Innospec Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 07, 2026お知らせ • Jan 12Innospec Inc. to Report Q4, 2025 Results on Feb 17, 2026Innospec Inc. announced that they will report Q4, 2025 results After-Market on Feb 17, 2026お知らせ • Oct 02Innospec Inc. to Report Q3, 2025 Results on Nov 04, 2025Innospec Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025お知らせ • Jul 03Innospec Inc. to Report Q2, 2025 Results on Aug 05, 2025Innospec Inc. announced that they will report Q2, 2025 results After-Market on Aug 05, 2025お知らせ • Apr 04Innospec Inc. to Report Q1, 2025 Results on May 08, 2025Innospec Inc. announced that they will report Q1, 2025 results After-Market on May 08, 2025お知らせ • Jan 09Innospec Inc. to Report Q4, 2024 Results on Feb 18, 2025Innospec Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025すべての更新を表示Recent updatesBoard Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Independent Non-Executive Director Les Parrette was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 10Innospec Inc. Declares Semi-Annual Dividend for the First Half of 2026, Payable on May 29, 2026Innospec Inc. declared its semi-annual dividend of 92 cents per common share for the first half of 2026, representing an increase of 10%. This dividend will be paid on May 29, 2026 to shareholders of record on May 19, 2026.お知らせ • May 08Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $75 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $75 million worth of its common stock.お知らせ • Apr 08Innospec Inc. to Report Q1, 2026 Results on May 07, 2026Innospec Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 07, 2026お知らせ • Mar 27Innospec Inc., Annual General Meeting, May 08, 2026Innospec Inc., Annual General Meeting, May 08, 2026. Location: the st. regis new york, two east 55th street, at fifth avenue, usa 10022, new york United Statesお知らせ • Jan 12Innospec Inc. to Report Q4, 2025 Results on Feb 17, 2026Innospec Inc. announced that they will report Q4, 2025 results After-Market on Feb 17, 2026お知らせ • Nov 05Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2025, Payable on November 26, 2025Innospec Inc. declared a semi-annual dividend of 87 cents per common share for the second half of 2025, which will be paid on November 26, 2025 to shareholders of record as of November 18, 2025.お知らせ • Oct 02Innospec Inc. to Report Q3, 2025 Results on Nov 04, 2025Innospec Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025お知らせ • Jul 03Innospec Inc. to Report Q2, 2025 Results on Aug 05, 2025Innospec Inc. announced that they will report Q2, 2025 results After-Market on Aug 05, 2025お知らせ • May 09Innospec Inc. Declares Semi-Annual Dividend, Payable on May 30, 2025Innospec Inc. declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10%. This dividend will be paid on May 30, 2025 to shareholders of record on May 20, 2025.お知らせ • Apr 04Innospec Inc. to Report Q1, 2025 Results on May 08, 2025Innospec Inc. announced that they will report Q1, 2025 results After-Market on May 08, 2025お知らせ • Mar 28Innospec Inc., Annual General Meeting, May 09, 2025Innospec Inc., Annual General Meeting, May 09, 2025. Location: westin at the woodlands hotel, 2 waterway square place, the woodlands, houston tx 77380, United Statesお知らせ • Mar 11Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $50 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its common stock.お知らせ • Jan 09Innospec Inc. to Report Q4, 2024 Results on Feb 18, 2025Innospec Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025Declared Dividend • Nov 11Dividend of US$0.79 announcedShareholders will receive a dividend of US$0.79. Ex-date: 18th November 2024 Payment date: 26th November 2024 Dividend yield will be 1.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 2 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 06Third quarter 2024 earnings released: EPS: US$1.34 (vs US$1.58 in 3Q 2023)Third quarter 2024 results: EPS: US$1.34 (down from US$1.58 in 3Q 2023). Revenue: US$443.4m (down 4.5% from 3Q 2023). Net income: US$33.4m (down 15% from 3Q 2023). Profit margin: 7.5% (down from 8.4% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 04Innospec Inc. to Report Q3, 2024 Results on Nov 06, 2024Innospec Inc. announced that they will report Q3, 2024 results on Nov 06, 2024Recent Insider Transactions • Aug 29Executive VP & CFO recently sold €1.0m worth of stockOn the 26th of August, Ian Cleminson sold around 10k shares on-market at roughly €102 per share. This transaction amounted to 49% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Ian has been a net seller over the last 12 months, reducing personal holdings by €1.5m.Reported Earnings • Aug 07Second quarter 2024 earnings released: EPS: US$1.25 (vs US$1.16 in 2Q 2023)Second quarter 2024 results: EPS: US$1.25 (up from US$1.16 in 2Q 2023). Revenue: US$435.0m (down 9.5% from 2Q 2023). Net income: US$31.2m (up 8.0% from 2Q 2023). Profit margin: 7.2% (up from 6.0% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.1% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 6.3% to €118. The fair value is estimated to be €96.79, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 4.0% in a year. Earnings are forecast to grow by 11% in the next year.お知らせ • Jul 04Innospec Inc. to Report Q2, 2024 Results on Aug 06, 2024Innospec Inc. announced that they will report Q2, 2024 results After-Market on Aug 06, 2024Buy Or Sell Opportunity • Jun 04Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 6.3% to €119. The fair value is estimated to be €98.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 4.7% in a year. Earnings are forecast to grow by 12% in the next year.Buy Or Sell Opportunity • May 12Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 8.9% to €122. The fair value is estimated to be €98.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 5.6% in a year. Earnings are forecast to grow by 12% in the next year.お知らせ • May 11Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2024Innospec Inc. declared its semi-annual dividend of 76 cents per common share for the first half of this year, representing an increase of 10%. This dividend will be paid on May 31, 2024 to shareholders of record on May 20, 2024.Reported Earnings • May 10First quarter 2024 earnings released: EPS: US$1.66 (vs US$1.34 in 1Q 2023)First quarter 2024 results: EPS: US$1.66 (up from US$1.34 in 1Q 2023). Revenue: US$500.2m (down 1.8% from 1Q 2023). Net income: US$41.4m (up 25% from 1Q 2023). Profit margin: 8.3% (up from 6.5% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Apr 10Now 20% undervaluedOver the last 90 days, the stock has risen 9.6% to €114. The fair value is estimated to be €143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 34%. Revenue is forecast to grow by 7.9% in 2 years. Earnings are forecast to grow by 25% in the next 2 years.お知らせ • Apr 06Innospec Inc. to Report Q1, 2024 Results on May 09, 2024Innospec Inc. announced that they will report Q1, 2024 results After-Market on May 09, 2024お知らせ • Apr 03Innospec Inc. Announces Retirement of Philip Boon, Executive Vice President and Chief Operating Officer Effective March 31, 2025On March 31, 2024, Dr. Philip Boon, Executive Vice President and Chief Operating Officer of Innospec Inc. (the “Company”), informed the Company of his decision to officially retire effective March 31, 2025. Dr. Boon will provide various support to the Company on a consultancy basis, on terms to be agreed, after his retirement.お知らせ • Mar 29Innospec Inc., Annual General Meeting, May 10, 2024Innospec Inc., Annual General Meeting, May 10, 2024, at 10:00 US Eastern Standard Time. Location: The offices of Smith, Gambrell & Russell LLP 1105 West Peachtree Street NE suite 1000 Atlanta Georgia United States Agenda: To consider election of two Class II Directors; to consider advisory approval of the Company’s executive compensation; to consider ratification of the appointment of the Company’s independent registered public accounting firm; and to discuss other matters.Recent Insider Transactions • Mar 08Senior VP recently sold €290k worth of stockOn the 1st of March, David Jones sold around 3k shares on-market at roughly €116 per share. This transaction amounted to 25% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.1m. Insiders have been net sellers, collectively disposing of €4.7m more than they bought in the last 12 months.Recent Insider Transactions • Feb 28President recently sold €1.1m worth of stockOn the 23rd of February, Patrick Williams sold around 10k shares on-market at roughly €115 per share. This transaction amounted to 5.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Patrick has been a net seller over the last 12 months, reducing personal holdings by €4.0m.Reported Earnings • Feb 14Full year 2023 earnings released: EPS: US$5.60 (vs US$5.37 in FY 2022)Full year 2023 results: EPS: US$5.60 (up from US$5.37 in FY 2022). Revenue: US$1.95b (flat on FY 2022). Net income: US$139.1m (up 4.6% from FY 2022). Profit margin: 7.1% (up from 6.8% in FY 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 12Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A.Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A. on December 8, 2023. Innospec will integrate QGP into its Performance Chemicals business. Innospec Inc. (NasdaqGS:IOSP) completed the acquisition of QGP Química Geral S.A. on December 8, 2023.Board Change • Dec 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Independent Non-Executive Director Les Parrette was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 09Third quarter 2023 earnings released: EPS: US$1.58 (vs US$1.56 in 3Q 2022)Third quarter 2023 results: EPS: US$1.58 (up from US$1.56 in 3Q 2022). Revenue: US$464.1m (down 9.5% from 3Q 2022). Net income: US$39.2m (up 1.3% from 3Q 2022). Profit margin: 8.4% (up from 7.5% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to stay flat during the next 3 years compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 08Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2023, Payable on November 27, 2023Innospec Inc. announced that it has declared a semi-annual dividend of 72 cents per common share for the second half of 2023 which will be paid on November 27, 2023 to shareholders of record as of November 20, 2023. This brings the annual dividend to $1.41 per share, a 10 percent increase over 2022.お知らせ • Aug 13Innospec Inc. to Report Q3, 2023 Results on Nov 07, 2023Innospec Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$1.16 (vs US$1.30 in 2Q 2022)Second quarter 2023 results: EPS: US$1.16 (down from US$1.30 in 2Q 2022). Revenue: US$480.4m (up 2.7% from 2Q 2022). Net income: US$28.9m (down 11% from 2Q 2022). Profit margin: 6.0% (down from 6.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.0% p.a. on average during the next 2 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 07Innospec Inc. to Report Q2, 2023 Results on Aug 08, 2023Innospec Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 08, 2023Upcoming Dividend • May 12Upcoming dividend of US$0.69 per share at 1.4% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 31 May 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.6%).お知らせ • May 05Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2023Innospec Inc. declared a semi-annual dividend of $0.69 per share on the Company’s common stock (IOSP). The dividend will be paid on May 31, 2023 to holders of record on May 22, 2023.Reported Earnings • May 04First quarter 2023 earnings released: EPS: US$1.34 (vs US$1.47 in 1Q 2022)First quarter 2023 results: EPS: US$1.34 (down from US$1.47 in 1Q 2022). Revenue: US$509.6m (up 7.9% from 1Q 2022). Net income: US$33.2m (down 9.0% from 1Q 2022). Profit margin: 6.5% (down from 7.7% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.9% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • Mar 03President recently sold €1.9m worth of stockOn the 28th of February, Patrick Williams sold around 18k shares on-market at roughly €104 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrick's only on-market trade for the last 12 months.Reported Earnings • Feb 23Full year 2022 earnings released: EPS: US$5.37 (vs US$3.78 in FY 2021)Full year 2022 results: EPS: US$5.37 (up from US$3.78 in FY 2021). Revenue: US$1.96b (up 32% from FY 2021). Net income: US$133.0m (up 43% from FY 2021). Profit margin: 6.8% (up from 6.3% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 1.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 11Innospec Inc. to Report Q4, 2022 Results on Feb 21, 2023Innospec Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 21, 2023Recent Insider Transactions • Dec 07Senior VP recently bought €77k worth of stockOn the 5th of December, David Jones bought around 752 shares on-market at roughly €103 per share. This transaction amounted to 97% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €610k more in shares than they bought in the last 12 months.Reported Earnings • Nov 10Third quarter 2022 earnings released: EPS: US$1.56 (vs US$0.95 in 3Q 2021)Third quarter 2022 results: EPS: US$1.56 (up from US$0.95 in 3Q 2021). Revenue: US$513.0m (up 36% from 3Q 2021). Net income: US$38.7m (up 65% from 3Q 2021). Profit margin: 7.5% (up from 6.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.3% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 09Innospec Inc. Declares Semi-Annual Dividend, Payable on November 28, 2022Innospec Inc. announced that it has declared a semi-annual dividend of 65 cents per common share for the second half of 2022 which will be paid on November 28, 2022 to shareholders of record as of November 21, 2022. This brings the annual dividend to $1.28 per share, a 10% increase over 2021.お知らせ • Oct 07Innospec Inc. to Report Q3, 2022 Results on Nov 08, 2022Innospec Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: US$1.30 (vs US$0.91 in 2Q 2021)Second quarter 2022 results: EPS: US$1.30 (up from US$0.91 in 2Q 2021). Revenue: US$467.6m (up 32% from 2Q 2021). Net income: US$32.3m (up 44% from 2Q 2021). Profit margin: 6.9% (up from 6.3% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.7%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 08Innospec Inc. to Report Q2, 2022 Results on Aug 02, 2022Innospec Inc. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 02, 2022Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to €89.50, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 8x in the Chemicals industry in Germany. Total returns to shareholders of 13% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €40.04 per share.Reported Earnings • May 05First quarter 2022 earnings released: EPS: US$1.47 (vs US$0.95 in 1Q 2021)First quarter 2022 results: EPS: US$1.47 (up from US$0.95 in 1Q 2021). Revenue: US$472.4m (up 39% from 1Q 2021). Net income: US$36.5m (up 56% from 1Q 2021). Profit margin: 7.7% (up from 6.9% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 3.5%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • May 05Innospec Inc. Declares Semi-Annual Dividend for the First Half of 2022, Payable on May 26, 2022Innospec Inc. announced the declaration of its semi-annual dividend of 63 cents per common share for the first half of 2022, representing an increase of 11% This dividend will be paid on May 26, 2022, to shareholders of record on May 17, 2022.お知らせ • Apr 07Innospec Inc. to Report Q1, 2022 Results on May 03, 2022Innospec Inc. announced that they will report Q1, 2022 results After-Market on May 03, 2022Recent Insider Transactions • Mar 04President recently sold €601k worth of stockOn the 25th of February, Patrick Williams sold around 7k shares on-market at roughly €85.90 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €2.2m.お知らせ • Feb 18Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $50 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its common stock. The program will run over the next three years from commencement date.Reported Earnings • Feb 16Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: US$3.78 (up from US$1.17 in FY 2020). Revenue: US$1.48b (up 24% from FY 2020). Net income: US$93.1m (up 224% from FY 2020). Profit margin: 6.3% (up from 2.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 5.2%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.お知らせ • Jan 06Innospec Secures China Approval for Its Ultra-Mild, Sulfate-Free Iselux® SurfactantsInnospec announces that Iselux® has been approved for use in China, the world’s second large personal care market. Available in liquid and solid form, Iselux® is a highly versatile, clear, mild and natural surfactant which delivers superior lather, skin feel and cleansing performance in more than 3,000 body, hair and other personal care products today. With the China approval secured, for the first time Iselux® is now available for worldwide cosmetic and personal care use by Innospec’s customers. Innospec technologies like Iselux® directly address growing long-term consumer demand for clean beauty without any compromise in product performance. Innospec recently announced plans for over $70MM of organic growth investments to be made through 2023 to support the increased demand outlook for its premium personal and home care technologies.Recent Insider Transactions • Nov 15President recently sold €968k worth of stockOn the 9th of November, Patrick Williams sold around 12k shares on-market at roughly €80.67 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €1.6m.Reported Earnings • Nov 04Third quarter 2021 earnings released: EPS US$0.95 (vs US$0.52 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$376.1m (up 42% from 3Q 2020). Net income: US$23.4m (up 84% from 3Q 2020). Profit margin: 6.2% (up from 4.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Reported Earnings • Aug 04Second quarter 2021 earnings released: EPS US$0.91 (vs US$1.62 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$354.5m (up 45% from 2Q 2020). Net income: US$22.4m (up US$62.1m from 2Q 2020). Profit margin: 6.3% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Recent Insider Transactions • May 13President recently sold €382k worth of stockOn the 7th of May, Patrick Williams sold around 5k shares on-market at roughly €83.67 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €928k.Reported Earnings • May 06First quarter 2021 earnings released: EPS US$0.95 (vs US$1.35 in 1Q 2020)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$339.6m (down 8.8% from 1Q 2020). Net income: US$23.4m (down 29% from 1Q 2020). Profit margin: 6.9% (down from 8.9% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • May 05Innospec Inc. Announces Semi-Annual Dividend for the First Half of 2021, Payable on May 26, 2021Innospec Inc. announced the declaration of its semi-annual dividend of $0.57 per common share for the first half of 2021, representing an increase of 10%. This dividend will be paid on May 26, 2021, to shareholders of record on May 17, 2021.Executive Departure • May 04Senior Vice President of Corporate Development & Investor Relations Brian Watt has left the companyOn the 30th of April, Brian Watt's tenure as Senior Vice President of Corporate Development & Investor Relations ended after 3.7 years in the role. We don't have any record of a personal shareholding under Brian's name. A total of 2 executives have left over the last 12 months.お知らせ • Mar 20Innospec Inc., Annual General Meeting, May 05, 2021Innospec Inc., Annual General Meeting, May 05, 2021, at 10:00 US Eastern Standard Time. Agenda: To consider election of two Class II Directors; to consider ratification of the election of one Class I Director; to consider advisory approval of the Company’s executive compensation; to consider ratification of the appointment of the Company’s independent registered public accounting firm.Is New 90 Day High Low • Feb 26New 90-day high: €84.00The company is up 17% from its price of €71.50 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.お知らせ • Feb 26Brian Watt Informs His Decision to Retire as Senior Vice President, Corporate Development and Investor Relations of Innospec Inc., Effective April 30, 2021On February 23, 2021, Mr. Brian Watt, Senior Vice President, Corporate Development and Investor Relations of Innospec Inc. (the 'Company'), informed the Company of his decision to officially retire effective April 30, 2021. The Company is discussing with Mr. Watt the possibility of him providing various support after his retirement.Reported Earnings • Feb 19Full year 2020 earnings released: EPS US$1.17 (vs US$4.58 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$1.19b (down 21% from FY 2019). Net income: US$28.7m (down 74% from FY 2019). Profit margin: 2.4% (down from 7.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 19Revenue beats expectationsRevenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 9.4%, compared to a 5.1% growth forecast for the Chemicals industry in Germany.お知らせ • Jan 19Innospec Inc. to Report Q4, 2020 Results on Feb 16, 2021Innospec Inc. announced that they will report Q4, 2020 results After-Market on Feb 16, 2021Valuation Update With 7 Day Price Move • Jan 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$83.00, the stock is trading at a trailing P/E ratio of 66.3x, up from the previous P/E ratio of 57.1x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 45%.Is New 90 Day High Low • Jan 08New 90-day high: €78.00The company is up 37% from its price of €57.00 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €26.34 per share.Is New 90 Day High Low • Dec 19New 90-day high: €73.50The company is up 30% from its price of €56.50 on 18 September 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.44 per share.Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 17% share price gain to US$72.00, the stock is trading at a trailing P/E ratio of 57.7x, up from the previous P/E ratio of 49.3x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 24%.Is New 90 Day High Low • Nov 16New 90-day high: €69.00The company is up 10.0% from its price of €63.00 on 18 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €130 per share.Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 19% share price gain to US$69.00, the stock is trading at a trailing P/E ratio of 52.7x, up from the previous P/E ratio of 44.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 24%.Upcoming Dividend • Nov 09Upcoming Dividend of US$0.52 Per ShareWill be paid on the 25th of November to those who are registered shareholders by the 16th of November. The trailing yield of 1.5% is below the top quartile of German dividend payers (3.8%), and is lower than industry peers (4.4%).Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS US$0.52The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$265.1m (down 29% from 3Q 2019). Net income: US$12.7m (down 58% from 3Q 2019). Profit margin: 4.8% (down from 8.1% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.Analyst Estimate Surprise Post Earnings • Nov 05Revenue misses expectationsRevenue missed analyst estimates by 4.5%. Over the next year, revenue is forecast to grow 4.6%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.お知らせ • Nov 03Innospec Inc. Appoints Elizabeth Keller Arnold as A Non-Employee DirectorInnospec Inc. announced that it has appointed Ms Elizabeth Keller Arnold as a non-employee director, effective November 1, 2020. After a long and successful career with General Electric and Tyco, Ms. Arnold was most recently Chief Financial Officer of Houghton International, a highly regarded global specialty chemical company. She is also an independent director of FreightCar America Inc. She has been appointed for an initial term until the 2021 Annual Stockholders Meeting and will also become a member of the Audit Committee.お知らせ • Oct 08Innospec Inc. to Report Q3, 2020 Results on Nov 03, 2020Innospec Inc. announced that they will report Q3, 2020 results at 5:00 PM, GMT Standard Time on Nov 03, 2020Is New 90 Day High Low • Sep 25New 90-day low: €53.00The company is down 18% from its price of €64.50 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.お知らせ • Jul 08Innospec Inc. to Report Q2, 2020 Results on Aug 04, 2020Innospec Inc. announced that they will report Q2, 2020 results at 5:00 PM, GMT Standard Time on Aug 04, 2020収支内訳Innospec の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:OCT 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 261,7901142955231 Dec 251,7781172855130 Sep 251,789-13014630 Jun 251,791192924631 Mar 251,786272795531 Dec 241,845362985730 Sep 241,8731443225130 Jun 241,8941503414931 Mar 241,9391473754531 Dec 231,9491393744930 Sep 231,9651273764130 Jun 232,0141263894031 Mar 232,0011303673931 Dec 221,9641333563930 Sep 221,8661313294030 Jun 221,7291163044031 Mar 221,6161062833931 Dec 211,483932623730 Sep 211,381922473430 Jun 211,270812303231 Mar 211,160192313131 Dec 201,193292373130 Sep 201,273372423330 Jun 201,380552593531 Mar 201,4971172663531 Dec 191,5131122743530 Sep 191,5181022713530 Jun 191,509922653431 Mar 191,505922603431 Dec 181,477852553330 Sep 181,436602563330 Jun 181,405632543331 Mar 181,373672503231 Dec 171,307622403130 Sep 171,191892333030 Jun 171,064772292831 Mar 17966802212631 Dec 16883812102530 Sep 16892912082630 Jun 169401152052631 Mar 169551212022631 Dec 151,0121202072530 Sep 151,0571161992430 Jun 151,03110118824質の高い収益: OCTは 高品質の収益 を持っています。利益率の向上: OCTの現在の純利益率 (6.4%)は、昨年(1.5%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: OCTの収益は過去 5 年間で年間3.8%減少しました。成長の加速: OCTの過去 1 年間の収益成長率 ( 323% ) は、5 年間の平均 ( 年間-3.8%を上回っています。収益対業界: OCTの過去 1 年間の収益成長率 ( 323% ) はChemicals業界-13.5%を上回りました。株主資本利益率高いROE: OCTの 自己資本利益率 ( 8.4% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 05:08終値2026/05/25 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Innospec Inc. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Jonathan TanwantengCJS Securities, Inc.David SilverFreedom Capital MarketsSean MilliganJohnson Rice & Company, L.L.C.4 その他のアナリストを表示
お知らせ • Apr 08Innospec Inc. to Report Q1, 2026 Results on May 07, 2026Innospec Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 07, 2026
お知らせ • Jan 12Innospec Inc. to Report Q4, 2025 Results on Feb 17, 2026Innospec Inc. announced that they will report Q4, 2025 results After-Market on Feb 17, 2026
お知らせ • Oct 02Innospec Inc. to Report Q3, 2025 Results on Nov 04, 2025Innospec Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025
お知らせ • Jul 03Innospec Inc. to Report Q2, 2025 Results on Aug 05, 2025Innospec Inc. announced that they will report Q2, 2025 results After-Market on Aug 05, 2025
お知らせ • Apr 04Innospec Inc. to Report Q1, 2025 Results on May 08, 2025Innospec Inc. announced that they will report Q1, 2025 results After-Market on May 08, 2025
お知らせ • Jan 09Innospec Inc. to Report Q4, 2024 Results on Feb 18, 2025Innospec Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Independent Non-Executive Director Les Parrette was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 10Innospec Inc. Declares Semi-Annual Dividend for the First Half of 2026, Payable on May 29, 2026Innospec Inc. declared its semi-annual dividend of 92 cents per common share for the first half of 2026, representing an increase of 10%. This dividend will be paid on May 29, 2026 to shareholders of record on May 19, 2026.
お知らせ • May 08Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $75 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $75 million worth of its common stock.
お知らせ • Apr 08Innospec Inc. to Report Q1, 2026 Results on May 07, 2026Innospec Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 07, 2026
お知らせ • Mar 27Innospec Inc., Annual General Meeting, May 08, 2026Innospec Inc., Annual General Meeting, May 08, 2026. Location: the st. regis new york, two east 55th street, at fifth avenue, usa 10022, new york United States
お知らせ • Jan 12Innospec Inc. to Report Q4, 2025 Results on Feb 17, 2026Innospec Inc. announced that they will report Q4, 2025 results After-Market on Feb 17, 2026
お知らせ • Nov 05Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2025, Payable on November 26, 2025Innospec Inc. declared a semi-annual dividend of 87 cents per common share for the second half of 2025, which will be paid on November 26, 2025 to shareholders of record as of November 18, 2025.
お知らせ • Oct 02Innospec Inc. to Report Q3, 2025 Results on Nov 04, 2025Innospec Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025
お知らせ • Jul 03Innospec Inc. to Report Q2, 2025 Results on Aug 05, 2025Innospec Inc. announced that they will report Q2, 2025 results After-Market on Aug 05, 2025
お知らせ • May 09Innospec Inc. Declares Semi-Annual Dividend, Payable on May 30, 2025Innospec Inc. declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10%. This dividend will be paid on May 30, 2025 to shareholders of record on May 20, 2025.
お知らせ • Apr 04Innospec Inc. to Report Q1, 2025 Results on May 08, 2025Innospec Inc. announced that they will report Q1, 2025 results After-Market on May 08, 2025
お知らせ • Mar 28Innospec Inc., Annual General Meeting, May 09, 2025Innospec Inc., Annual General Meeting, May 09, 2025. Location: westin at the woodlands hotel, 2 waterway square place, the woodlands, houston tx 77380, United States
お知らせ • Mar 11Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $50 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its common stock.
お知らせ • Jan 09Innospec Inc. to Report Q4, 2024 Results on Feb 18, 2025Innospec Inc. announced that they will report Q4, 2024 results After-Market on Feb 18, 2025
Declared Dividend • Nov 11Dividend of US$0.79 announcedShareholders will receive a dividend of US$0.79. Ex-date: 18th November 2024 Payment date: 26th November 2024 Dividend yield will be 1.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (26% earnings payout ratio) and cash flows (23% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 06Third quarter 2024 earnings released: EPS: US$1.34 (vs US$1.58 in 3Q 2023)Third quarter 2024 results: EPS: US$1.34 (down from US$1.58 in 3Q 2023). Revenue: US$443.4m (down 4.5% from 3Q 2023). Net income: US$33.4m (down 15% from 3Q 2023). Profit margin: 7.5% (down from 8.4% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 04Innospec Inc. to Report Q3, 2024 Results on Nov 06, 2024Innospec Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
Recent Insider Transactions • Aug 29Executive VP & CFO recently sold €1.0m worth of stockOn the 26th of August, Ian Cleminson sold around 10k shares on-market at roughly €102 per share. This transaction amounted to 49% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Ian has been a net seller over the last 12 months, reducing personal holdings by €1.5m.
Reported Earnings • Aug 07Second quarter 2024 earnings released: EPS: US$1.25 (vs US$1.16 in 2Q 2023)Second quarter 2024 results: EPS: US$1.25 (up from US$1.16 in 2Q 2023). Revenue: US$435.0m (down 9.5% from 2Q 2023). Net income: US$31.2m (up 8.0% from 2Q 2023). Profit margin: 7.2% (up from 6.0% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.1% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 6.3% to €118. The fair value is estimated to be €96.79, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 4.0% in a year. Earnings are forecast to grow by 11% in the next year.
お知らせ • Jul 04Innospec Inc. to Report Q2, 2024 Results on Aug 06, 2024Innospec Inc. announced that they will report Q2, 2024 results After-Market on Aug 06, 2024
Buy Or Sell Opportunity • Jun 04Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 6.3% to €119. The fair value is estimated to be €98.70, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 4.7% in a year. Earnings are forecast to grow by 12% in the next year.
Buy Or Sell Opportunity • May 12Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 8.9% to €122. The fair value is estimated to be €98.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 5.6% in a year. Earnings are forecast to grow by 12% in the next year.
お知らせ • May 11Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2024Innospec Inc. declared its semi-annual dividend of 76 cents per common share for the first half of this year, representing an increase of 10%. This dividend will be paid on May 31, 2024 to shareholders of record on May 20, 2024.
Reported Earnings • May 10First quarter 2024 earnings released: EPS: US$1.66 (vs US$1.34 in 1Q 2023)First quarter 2024 results: EPS: US$1.66 (up from US$1.34 in 1Q 2023). Revenue: US$500.2m (down 1.8% from 1Q 2023). Net income: US$41.4m (up 25% from 1Q 2023). Profit margin: 8.3% (up from 6.5% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Apr 10Now 20% undervaluedOver the last 90 days, the stock has risen 9.6% to €114. The fair value is estimated to be €143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 34%. Revenue is forecast to grow by 7.9% in 2 years. Earnings are forecast to grow by 25% in the next 2 years.
お知らせ • Apr 06Innospec Inc. to Report Q1, 2024 Results on May 09, 2024Innospec Inc. announced that they will report Q1, 2024 results After-Market on May 09, 2024
お知らせ • Apr 03Innospec Inc. Announces Retirement of Philip Boon, Executive Vice President and Chief Operating Officer Effective March 31, 2025On March 31, 2024, Dr. Philip Boon, Executive Vice President and Chief Operating Officer of Innospec Inc. (the “Company”), informed the Company of his decision to officially retire effective March 31, 2025. Dr. Boon will provide various support to the Company on a consultancy basis, on terms to be agreed, after his retirement.
お知らせ • Mar 29Innospec Inc., Annual General Meeting, May 10, 2024Innospec Inc., Annual General Meeting, May 10, 2024, at 10:00 US Eastern Standard Time. Location: The offices of Smith, Gambrell & Russell LLP 1105 West Peachtree Street NE suite 1000 Atlanta Georgia United States Agenda: To consider election of two Class II Directors; to consider advisory approval of the Company’s executive compensation; to consider ratification of the appointment of the Company’s independent registered public accounting firm; and to discuss other matters.
Recent Insider Transactions • Mar 08Senior VP recently sold €290k worth of stockOn the 1st of March, David Jones sold around 3k shares on-market at roughly €116 per share. This transaction amounted to 25% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €1.1m. Insiders have been net sellers, collectively disposing of €4.7m more than they bought in the last 12 months.
Recent Insider Transactions • Feb 28President recently sold €1.1m worth of stockOn the 23rd of February, Patrick Williams sold around 10k shares on-market at roughly €115 per share. This transaction amounted to 5.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Patrick has been a net seller over the last 12 months, reducing personal holdings by €4.0m.
Reported Earnings • Feb 14Full year 2023 earnings released: EPS: US$5.60 (vs US$5.37 in FY 2022)Full year 2023 results: EPS: US$5.60 (up from US$5.37 in FY 2022). Revenue: US$1.95b (flat on FY 2022). Net income: US$139.1m (up 4.6% from FY 2022). Profit margin: 7.1% (up from 6.8% in FY 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 2.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 12Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A.Innospec Inc. (NasdaqGS:IOSP) acquired QGP Química Geral S.A. on December 8, 2023. Innospec will integrate QGP into its Performance Chemicals business. Innospec Inc. (NasdaqGS:IOSP) completed the acquisition of QGP Química Geral S.A. on December 8, 2023.
Board Change • Dec 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Independent Non-Executive Director Les Parrette was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 09Third quarter 2023 earnings released: EPS: US$1.58 (vs US$1.56 in 3Q 2022)Third quarter 2023 results: EPS: US$1.58 (up from US$1.56 in 3Q 2022). Revenue: US$464.1m (down 9.5% from 3Q 2022). Net income: US$39.2m (up 1.3% from 3Q 2022). Profit margin: 8.4% (up from 7.5% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to stay flat during the next 3 years compared to a 3.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 08Innospec Inc. Declares Semi-Annual Dividend for the Second Half of 2023, Payable on November 27, 2023Innospec Inc. announced that it has declared a semi-annual dividend of 72 cents per common share for the second half of 2023 which will be paid on November 27, 2023 to shareholders of record as of November 20, 2023. This brings the annual dividend to $1.41 per share, a 10 percent increase over 2022.
お知らせ • Aug 13Innospec Inc. to Report Q3, 2023 Results on Nov 07, 2023Innospec Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 07, 2023
Reported Earnings • Aug 09Second quarter 2023 earnings released: EPS: US$1.16 (vs US$1.30 in 2Q 2022)Second quarter 2023 results: EPS: US$1.16 (down from US$1.30 in 2Q 2022). Revenue: US$480.4m (up 2.7% from 2Q 2022). Net income: US$28.9m (down 11% from 2Q 2022). Profit margin: 6.0% (down from 6.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.0% p.a. on average during the next 2 years, compared to a 1.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 07Innospec Inc. to Report Q2, 2023 Results on Aug 08, 2023Innospec Inc. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 08, 2023
Upcoming Dividend • May 12Upcoming dividend of US$0.69 per share at 1.4% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 31 May 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.6%).
お知らせ • May 05Innospec Inc. Declares Semi-Annual Dividend, Payable on May 31, 2023Innospec Inc. declared a semi-annual dividend of $0.69 per share on the Company’s common stock (IOSP). The dividend will be paid on May 31, 2023 to holders of record on May 22, 2023.
Reported Earnings • May 04First quarter 2023 earnings released: EPS: US$1.34 (vs US$1.47 in 1Q 2022)First quarter 2023 results: EPS: US$1.34 (down from US$1.47 in 1Q 2022). Revenue: US$509.6m (up 7.9% from 1Q 2022). Net income: US$33.2m (down 9.0% from 1Q 2022). Profit margin: 6.5% (down from 7.7% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.9% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • Mar 03President recently sold €1.9m worth of stockOn the 28th of February, Patrick Williams sold around 18k shares on-market at roughly €104 per share. This transaction amounted to 10% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrick's only on-market trade for the last 12 months.
Reported Earnings • Feb 23Full year 2022 earnings released: EPS: US$5.37 (vs US$3.78 in FY 2021)Full year 2022 results: EPS: US$5.37 (up from US$3.78 in FY 2021). Revenue: US$1.96b (up 32% from FY 2021). Net income: US$133.0m (up 43% from FY 2021). Profit margin: 6.8% (up from 6.3% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 1.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 11Innospec Inc. to Report Q4, 2022 Results on Feb 21, 2023Innospec Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Feb 21, 2023
Recent Insider Transactions • Dec 07Senior VP recently bought €77k worth of stockOn the 5th of December, David Jones bought around 752 shares on-market at roughly €103 per share. This transaction amounted to 97% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €610k more in shares than they bought in the last 12 months.
Reported Earnings • Nov 10Third quarter 2022 earnings released: EPS: US$1.56 (vs US$0.95 in 3Q 2021)Third quarter 2022 results: EPS: US$1.56 (up from US$0.95 in 3Q 2021). Revenue: US$513.0m (up 36% from 3Q 2021). Net income: US$38.7m (up 65% from 3Q 2021). Profit margin: 7.5% (up from 6.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.3% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 09Innospec Inc. Declares Semi-Annual Dividend, Payable on November 28, 2022Innospec Inc. announced that it has declared a semi-annual dividend of 65 cents per common share for the second half of 2022 which will be paid on November 28, 2022 to shareholders of record as of November 21, 2022. This brings the annual dividend to $1.28 per share, a 10% increase over 2021.
お知らせ • Oct 07Innospec Inc. to Report Q3, 2022 Results on Nov 08, 2022Innospec Inc. announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022
Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: US$1.30 (vs US$0.91 in 2Q 2021)Second quarter 2022 results: EPS: US$1.30 (up from US$0.91 in 2Q 2021). Revenue: US$467.6m (up 32% from 2Q 2021). Net income: US$32.3m (up 44% from 2Q 2021). Profit margin: 6.9% (up from 6.3% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.7%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 08Innospec Inc. to Report Q2, 2022 Results on Aug 02, 2022Innospec Inc. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 02, 2022
Valuation Update With 7 Day Price Move • Jul 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to €89.50, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 8x in the Chemicals industry in Germany. Total returns to shareholders of 13% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €40.04 per share.
Reported Earnings • May 05First quarter 2022 earnings released: EPS: US$1.47 (vs US$0.95 in 1Q 2021)First quarter 2022 results: EPS: US$1.47 (up from US$0.95 in 1Q 2021). Revenue: US$472.4m (up 39% from 1Q 2021). Net income: US$36.5m (up 56% from 1Q 2021). Profit margin: 7.7% (up from 6.9% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 3.5%, compared to a 8.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • May 05Innospec Inc. Declares Semi-Annual Dividend for the First Half of 2022, Payable on May 26, 2022Innospec Inc. announced the declaration of its semi-annual dividend of 63 cents per common share for the first half of 2022, representing an increase of 11% This dividend will be paid on May 26, 2022, to shareholders of record on May 17, 2022.
お知らせ • Apr 07Innospec Inc. to Report Q1, 2022 Results on May 03, 2022Innospec Inc. announced that they will report Q1, 2022 results After-Market on May 03, 2022
Recent Insider Transactions • Mar 04President recently sold €601k worth of stockOn the 25th of February, Patrick Williams sold around 7k shares on-market at roughly €85.90 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €2.2m.
お知らせ • Feb 18Innospec Inc. (NasdaqGS:IOSP) announces an Equity Buyback for $50 million worth of its shares.Innospec Inc. (NasdaqGS:IOSP) announces a share repurchase program. Under the program, the company will repurchase up to $50 million worth of its common stock. The program will run over the next three years from commencement date.
Reported Earnings • Feb 16Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: US$3.78 (up from US$1.17 in FY 2020). Revenue: US$1.48b (up 24% from FY 2020). Net income: US$93.1m (up 224% from FY 2020). Profit margin: 6.3% (up from 2.4% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 5.2%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
お知らせ • Jan 06Innospec Secures China Approval for Its Ultra-Mild, Sulfate-Free Iselux® SurfactantsInnospec announces that Iselux® has been approved for use in China, the world’s second large personal care market. Available in liquid and solid form, Iselux® is a highly versatile, clear, mild and natural surfactant which delivers superior lather, skin feel and cleansing performance in more than 3,000 body, hair and other personal care products today. With the China approval secured, for the first time Iselux® is now available for worldwide cosmetic and personal care use by Innospec’s customers. Innospec technologies like Iselux® directly address growing long-term consumer demand for clean beauty without any compromise in product performance. Innospec recently announced plans for over $70MM of organic growth investments to be made through 2023 to support the increased demand outlook for its premium personal and home care technologies.
Recent Insider Transactions • Nov 15President recently sold €968k worth of stockOn the 9th of November, Patrick Williams sold around 12k shares on-market at roughly €80.67 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €1.6m.
Reported Earnings • Nov 04Third quarter 2021 earnings released: EPS US$0.95 (vs US$0.52 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$376.1m (up 42% from 3Q 2020). Net income: US$23.4m (up 84% from 3Q 2020). Profit margin: 6.2% (up from 4.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 04Second quarter 2021 earnings released: EPS US$0.91 (vs US$1.62 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$354.5m (up 45% from 2Q 2020). Net income: US$22.4m (up US$62.1m from 2Q 2020). Profit margin: 6.3% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Recent Insider Transactions • May 13President recently sold €382k worth of stockOn the 7th of May, Patrick Williams sold around 5k shares on-market at roughly €83.67 per share. This was the largest sale by an insider in the last 3 months. Patrick has been a seller over the last 12 months, reducing personal holdings by €928k.
Reported Earnings • May 06First quarter 2021 earnings released: EPS US$0.95 (vs US$1.35 in 1Q 2020)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$339.6m (down 8.8% from 1Q 2020). Net income: US$23.4m (down 29% from 1Q 2020). Profit margin: 6.9% (down from 8.9% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • May 05Innospec Inc. Announces Semi-Annual Dividend for the First Half of 2021, Payable on May 26, 2021Innospec Inc. announced the declaration of its semi-annual dividend of $0.57 per common share for the first half of 2021, representing an increase of 10%. This dividend will be paid on May 26, 2021, to shareholders of record on May 17, 2021.
Executive Departure • May 04Senior Vice President of Corporate Development & Investor Relations Brian Watt has left the companyOn the 30th of April, Brian Watt's tenure as Senior Vice President of Corporate Development & Investor Relations ended after 3.7 years in the role. We don't have any record of a personal shareholding under Brian's name. A total of 2 executives have left over the last 12 months.
お知らせ • Mar 20Innospec Inc., Annual General Meeting, May 05, 2021Innospec Inc., Annual General Meeting, May 05, 2021, at 10:00 US Eastern Standard Time. Agenda: To consider election of two Class II Directors; to consider ratification of the election of one Class I Director; to consider advisory approval of the Company’s executive compensation; to consider ratification of the appointment of the Company’s independent registered public accounting firm.
Is New 90 Day High Low • Feb 26New 90-day high: €84.00The company is up 17% from its price of €71.50 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.
お知らせ • Feb 26Brian Watt Informs His Decision to Retire as Senior Vice President, Corporate Development and Investor Relations of Innospec Inc., Effective April 30, 2021On February 23, 2021, Mr. Brian Watt, Senior Vice President, Corporate Development and Investor Relations of Innospec Inc. (the 'Company'), informed the Company of his decision to officially retire effective April 30, 2021. The Company is discussing with Mr. Watt the possibility of him providing various support after his retirement.
Reported Earnings • Feb 19Full year 2020 earnings released: EPS US$1.17 (vs US$4.58 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$1.19b (down 21% from FY 2019). Net income: US$28.7m (down 74% from FY 2019). Profit margin: 2.4% (down from 7.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 19Revenue beats expectationsRevenue exceeded analyst estimates by 2.3%. Over the next year, revenue is forecast to grow 9.4%, compared to a 5.1% growth forecast for the Chemicals industry in Germany.
お知らせ • Jan 19Innospec Inc. to Report Q4, 2020 Results on Feb 16, 2021Innospec Inc. announced that they will report Q4, 2020 results After-Market on Feb 16, 2021
Valuation Update With 7 Day Price Move • Jan 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$83.00, the stock is trading at a trailing P/E ratio of 66.3x, up from the previous P/E ratio of 57.1x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 45%.
Is New 90 Day High Low • Jan 08New 90-day high: €78.00The company is up 37% from its price of €57.00 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €26.34 per share.
Is New 90 Day High Low • Dec 19New 90-day high: €73.50The company is up 30% from its price of €56.50 on 18 September 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €28.44 per share.
Valuation Update With 7 Day Price Move • Nov 26Market bids up stock over the past weekAfter last week's 17% share price gain to US$72.00, the stock is trading at a trailing P/E ratio of 57.7x, up from the previous P/E ratio of 49.3x. This compares to an average P/E of 27x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 24%.
Is New 90 Day High Low • Nov 16New 90-day high: €69.00The company is up 10.0% from its price of €63.00 on 18 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €130 per share.
Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 19% share price gain to US$69.00, the stock is trading at a trailing P/E ratio of 52.7x, up from the previous P/E ratio of 44.3x. This compares to an average P/E of 26x in the Chemicals industry in Germany. Total returns to shareholders over the past three years are 24%.
Upcoming Dividend • Nov 09Upcoming Dividend of US$0.52 Per ShareWill be paid on the 25th of November to those who are registered shareholders by the 16th of November. The trailing yield of 1.5% is below the top quartile of German dividend payers (3.8%), and is lower than industry peers (4.4%).
Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS US$0.52The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$265.1m (down 29% from 3Q 2019). Net income: US$12.7m (down 58% from 3Q 2019). Profit margin: 4.8% (down from 8.1% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue misses expectationsRevenue missed analyst estimates by 4.5%. Over the next year, revenue is forecast to grow 4.6%, compared to a 2.3% growth forecast for the Chemicals industry in Germany.
お知らせ • Nov 03Innospec Inc. Appoints Elizabeth Keller Arnold as A Non-Employee DirectorInnospec Inc. announced that it has appointed Ms Elizabeth Keller Arnold as a non-employee director, effective November 1, 2020. After a long and successful career with General Electric and Tyco, Ms. Arnold was most recently Chief Financial Officer of Houghton International, a highly regarded global specialty chemical company. She is also an independent director of FreightCar America Inc. She has been appointed for an initial term until the 2021 Annual Stockholders Meeting and will also become a member of the Audit Committee.
お知らせ • Oct 08Innospec Inc. to Report Q3, 2020 Results on Nov 03, 2020Innospec Inc. announced that they will report Q3, 2020 results at 5:00 PM, GMT Standard Time on Nov 03, 2020
Is New 90 Day High Low • Sep 25New 90-day low: €53.00The company is down 18% from its price of €64.50 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.
お知らせ • Jul 08Innospec Inc. to Report Q2, 2020 Results on Aug 04, 2020Innospec Inc. announced that they will report Q2, 2020 results at 5:00 PM, GMT Standard Time on Aug 04, 2020